Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases

被引：13
作者：
Jiang, Shufan [1 ,2 ]
Yang, Huili [1 ]
Li, Mingqing [1 ,3 ]
机构：
[1] Fudan Univ, Hosp Obstet & Gynecol, Lab Reprod Immunol, Shanghai 200080, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Shanghai 200032, Peoples R China
[3] Fudan Univ, Hosp Obstet & Gynecol, Shanghai Key Lab Female Reprod Endocrine Related D, Shanghai 200080, Peoples R China
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 15期
基金：
中国国家自然科学基金;
关键词：
lysophosphatidic acid; lysophosphatidic acid receptor; macrophage; inflammation; atherosclerosis; fibrosis; PROTEIN-COUPLED RECEPTOR; OVARIAN-CANCER CELLS; INDUCED LUNG INJURY; PROMOTES ATHEROSCLEROSIS; THERAPEUTIC TARGET; GROWTH-FACTOR; TGF-BETA; EXPRESSION; AUTOTAXIN; LPA;
D O I：
10.3390/ijms241512524
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Lysophosphatidic acid (LPA) is a bioactive phospholipid that regulates physiological and pathological processes in numerous cell biological functions, including cell migration, apoptosis, and proliferation. Macrophages are found in most human tissues and have multiple physiological and pathological functions. There is growing evidence that LPA signaling plays a significant role in the physiological function of macrophages and accelerates the development of diseases caused by macrophage dysfunction and inflammation, such as inflammation-related diseases, cancer, atherosclerosis, and fibrosis. In this review, we summarize the roles of LPA in macrophages, analyze numerous macrophage- and inflammation-associated diseases triggered by LPA, and discuss LPA-targeting therapeutic strategies.
引用
收藏
页数：19
相关论文
共 146 条
  • [1] Polyunsaturated lysophosphatidic acid as a potential asthma biomarker
    Ackerman, Steven J.
    Park, Gye Young
    Christman, John W.
    Nyenhuis, Sharmilee
    Berdyshev, Evgeny
    Natarajan, Viswanathan
    [J]. BIOMARKERS IN MEDICINE, 2016, 10 (02) : 123 - 135
  • [2] Endothelial Hypoxia-Inducible Factor-1α Promotes Atherosclerosis and Monocyte Recruitment by Upregulating MicroRNA-19a
    Akhtar, Shamima
    Hartmann, Petra
    Karshovska, Ela
    Rinderknecht, Fatuma-Ayaan
    Subramanian, Pallavi
    Gremse, Felix
    Grommes, Jochen
    Jacobs, Michael
    Kiessling, Fabian
    Weber, Christian
    Steffens, Sabine
    Schober, Andreas
    [J]. HYPERTENSION, 2015, 66 (06) : 1220 - 1226
  • [3] Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis
    Aldi, Silvia
    Matic, Ljubica Perisic
    Hamm, Gregory
    van Keulen, Danielle
    Tempel, Dennie
    Holmstrom, Kim
    Szwajda, Agnieszka
    Nielsen, Boye Schnack
    Emilsson, Valur
    Ait-Belkacem, Rima
    Lengquist, Mariette
    Paulsson-Berne, Gabrielle
    Eriksson, Per
    Lindeman, Jan H. N.
    Gool, Alain J.
    Stauber, Jonathan
    Hedin, Ulf
    Hurt-Camejo, Eva
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2018, 10 : 17 - 28
  • [4] Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension Study
    Allanore, Yannick
    Distler, Oliver
    Jagerschmidt, Alexandre
    Illiano, Stephane
    Ledein, Laetitia
    Boitier, Eric
    Agueusop, Inoncent
    Denton, Christopher P.
    Khanna, Dinesh
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70 (10) : 1634 - 1643
  • [5] Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA1receptor
    Amaral, Rackele F.
    Geraldo, Luiz H. M.
    Einicker-Lamas, Marcelo
    Spohr, Tania C. L. de S. e
    Mendes, Fabio
    Lima, Flavia R. S.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2021, 156 (04) : 499 - 512
  • [6] Pulmonary Hypertension in Bronchopulmonary Dysplasia
    Ambalavanan, Namasivayam
    Mourani, Peter
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2014, 100 (03) : 240 - 246
  • [7] CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation
    An, Dong
    Hao, Feng
    Zhang, Fuqiang
    Kong, Wei
    Chun, Jerold
    Xu, Xuemin
    Cui, Mei-Zhen
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (35) : 14391 - 14400
  • [8] Serum lysophosphatidic acid is produced through diverse phospholipase pathways
    Aoki, J
    Taira, A
    Takanezawa, Y
    Kishi, Y
    Hama, K
    Kishimoto, T
    Mizuno, K
    Saku, K
    Taguchi, R
    Arai, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) : 48737 - 48744
  • [9] Two pathways for lysophosphatidic acid production
    Aoki, Junken
    Inoue, Asuka
    Okudaira, Shinichi
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2008, 1781 (09): : 513 - 518
  • [10] Origin, Differentiation, and Function of Intestinal Macrophages
    Bain, Calum C.
    Schridde, Anika
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
12345678910